eli lilly phase 3 trial retatrutide obesity results 2026 Everyone is calling retatrutide a

The research concludes that for food manufacturers, restaurants and retailers, widespread GLP-1 adoption could lead to long-term shifts in demand, particularly for snack foods and fast food

Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis

Metformin still earns its place as first-line therapy for the metabolic piece of this condition

AkarAArcaEErbilHAkayCSayalAGrAR

These converging pathways suggest that future interventions might achieve enhanced efficacy by simultaneously targeting inflammation, neural repair, and microbiota balance